Find and Pitch Jounalists, Get Your Story Covered

Tags: biotechnology CRISPR drug development FDA Pharmaceuticals

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Biotechs emerging from stealth take aim at pharma’s prime targets - about 1 month ago 4 companies to watch in the accelerating gene editing race - 4 months ago Who’s winning in biotech’s tight market? - 7 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 8 months ago
2	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The view from overseas on tumult in U.S. science - 2 months ago The biotech news stories we’re keeping an eye on - 3 months ago Eli Lilly seeks to join lawsuit on compounded drugs - 4 months ago Merck is a new year outlier with its diabetes drug - 4 months ago The biotech news you need to read today - 5 months ago Element Biosciences raises another massive round - 10 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 11 months ago How resurrecting extinct species might impact medicine - about 1 year ago Lawmakers want to add more Chinese biotechs to defense list - about 1 year ago The biotech updates you need to read today - over 1 year ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - over 1 year ago Novartis is building a new radioligand plant in China - over 1 year ago A new algorithm unveils CRISPR ‘treasure trove’ - over 1 year ago These are the need-to-know biotech stories from this weekend - over 1 year ago Shrinking Covid vaccine sales has Moderna course-correcting - over 1 year ago
3	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Biotech is in a dark place - 2 months ago STAT+: Biotech companies detail emerging efforts to ease ‘conditioning’ before genetic treatments - 5 months ago A biotech’s binary bet ends badly - 10 months ago
4	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Is Trump’s new order a reprieve for biotech? - 2 months ago East Asians under-represented in biopharma leadership - 4 months ago A key decision on compounding is expected this week - 4 months ago Gameto says first baby born using new stem-cell tech - 4 months ago STAT+: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu - 11 months ago
5	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Capgemini unveils AI breakthrough to boost bioeconomy - 2 months ago
6	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	A biotech’s race to tackle the most severe hepatitis - 4 months ago Milk-based therapies could be coming. This biotech CEO is aiming to lead the way. - 5 months ago Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - 8 months ago 4 offbeat biotechs making a splash in the life sciences - 12 months ago These biotech hotspots are ripe for IPOs - about 1 year ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio Roots - 4 months ago Flagship Pioneering Launches Startup Abiologics to Advance New Class of Biologic Drugs - 9 months ago
8	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers - 6 months ago 2024 PharmaVoice 100s: Biotech Pathfinders - 6 months ago A plucky biotech threatening Pfizer’s grip on the Prevnar vaccine market - 8 months ago A biotech dousing ‘fires’ in the brain that plagued a bestselling author - 9 months ago Protein power: a biotech mining viruses to fight disease - 10 months ago Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections - 10 months ago 3 up-and-coming US biotech hotspots - 11 months ago Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future - about 1 year ago With a rise in animal-human organ transplants, a drugmaker aims for a new standard of care - about 1 year ago An ocean of answers in a single cell — how proteomics can lead to better drugs - about 1 year ago How to make 2024 a banner year for biopharma, despite the headwinds - over 1 year ago One biotech’s 3 gene therapy hurdles: delivery, delivery and delivery - over 1 year ago This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain - over 1 year ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago
9	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present - 7 months ago STAT+: With biotech in a slump, the industry’s job market is upside down - over 1 year ago
10	Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto ScienceFreelance Writing	Better Living Through Algae Biotechnology - 7 months ago

Journalists covering biotech